TrialHuman vaccines & immunotherapeutics2015

Safety and persistence of the humoral and cellular immune responses induced by 2 doses of an AS03-adjuvanted A(H1N1)pdm09 pandemic influenza vaccine administered to infants, children and adolescents: Two open, uncontrolled studies.

José Garcia-Sicilia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.